Open AccessS0345 Safety and Efficacy of Long-Term Treatment of EoE With Fluticasone Propionate Orally Disintegrating Tablet (APT-1011): Results From 40 Weeks Treatment in a Phase 2b Randomized Double-Blind Placebo-Controlled Trial
Author(s) -
Evan S. Dellon,
Alfredo J. Lucendo,
Christoph Schlag,
Alain Schoepher,
Gary W. Falk,
Peter J. Richardson,
Gina Eagle,
James Nezamis,
Gail M. Comer,
Karol Knoop,
Ikuo Hirano
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000703428.23468.41
Subject(s) - medicine , placebo , eosinophilic esophagitis , fluticasone propionate , gastroenterology , randomized controlled trial , adverse effect , corticosteroid , pathology , disease , alternative medicine